Regencell Bioscience Holdings (Regencell Bioscience Holdings) Interest Expense

: $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Regencell Bioscience Holdings's interest expense for the six months ended in Jun. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Regencell Bioscience Holdings's Operating Income for the six months ended in Jun. 2023 was $ -2.84 Mil. Regencell Bioscience Holdings's Interest Expense for the six months ended in Jun. 2023 was $ 0.00 Mil. GuruFocus does not calculate Regencell Bioscience Holdings's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Regencell Bioscience Holdings Interest Expense Historical Data

The historical data trend for Regencell Bioscience Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial				-	-	-	-	-

Regencell Bioscience Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Regencell Bioscience Holdings (NAS:RGC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Regencell Bioscience Holdings's Interest Expense for the six months ended in Jun. 2023 was $0.00 Mil. Its Operating Income for the six months ended in Jun. 2023 was $-2.84 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was $0.03 Mil.

Regencell Bioscience Holdings's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

GuruFocus does not calculate Regencell Bioscience Holdings's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Regencell Bioscience Holdings Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.